Discovery of a novel oral, non-RGD pan-αv integrin inhibitor for castration resistant prostate cancer treatment

被引：0
|
作者：
Gu, Yanlun [1 ,4 ]
Sun, Xiaojiao [2 ]
Dong, Bingqi [3 ]
Song, Song [2 ]
Liu, Zhenming [2 ]
Pang, Xiaocong [1 ,4 ]
Cui, Yimin [1 ,4 ]
机构：
[1] Peking Univ First Hosp, Dept Pharm, Beijing, Peoples R China
[2] Peking Univ, Sch Pharmaceut Sci, Beijing, Peoples R China
[3] Peking Univ First Hosp, Dept Gen Surg, Beijing, Peoples R China
[4] Peking Univ, Inst Clin Pharmacol, Beijing, Peoples R China
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2023年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P0651
引用
收藏
页码：508 / 509
页数：2
相关论文
共 50 条
  • [1] Discovery of C19-9 as a novel non-RGD inhibitor of αvβ3 to overcome enzalutamide resistance in castration-resistant prostate cancer
    Xiaocong Pang
    Xiaojiao Sun
    Yanlun Gu
    Xu He
    Kan Gong
    Song Song
    Jixin Zhang
    Jie Xia
    Zhenming Liu
    Yimin Cui
    Signal Transduction and Targeted Therapy, 8
  • [2] Discovery of C19-9 as a novel non-RGD inhibitor of αvβ3 to overcome enzalutamide resistance in castration-resistant prostate cancer
    Pang, Xiaocong
    Sun, Xiaojiao
    Gu, Yanlun
    He, Xu
    Gong, Kan
    Song, Song
    Zhang, Jixin
    Xia, Jie
    Liu, Zhenming
    Cui, Yimin
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [3] Enzalutamide, an oral androgen receptor inhibitor for treatment of castration-resistant prostate cancer
    Sternberg, Cora N.
    FUTURE ONCOLOGY, 2019, 15 (13) : 1437 - 1457
  • [4] Oral etoposide and oral prednisone for the treatment of castration resistant prostate cancer
    Zhu, Yi-Ping
    Yao, Xu-Dong
    Zhang, Shi-Lin
    Dai, Bo
    Zhang, Hai-Liang
    Shen, Yi-Jun
    Zhu, Yao
    Shi, Guo-Hai
    Lin, Guo-Wen
    Ye, Ding-Wei
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2014, 30 (02) : 82 - 85
  • [5] Abiraterone acetate: oral androgen biosynthesis inhibitor for treatment of castration-resistant prostate cancer
    Rehman, Yasser
    Rosenberg, Jonathan E.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2012, 6 : 13 - 18
  • [6] Novel options for the treatment of castration-resistant prostate cancer
    Ohlmann, Carsten-H.
    Merseburger, Axel S.
    Suttmann, Henrik
    Schilling, David
    Trojan, Lutz
    Kempkensteffen, Carsten
    Corvin, Stefan
    Mathers, Michael J.
    Bastian, Patrick J.
    WORLD JOURNAL OF UROLOGY, 2012, 30 (04) : 495 - 503
  • [7] Novel options for the treatment of castration-resistant prostate cancer
    Carsten-H. Ohlmann
    Axel S. Merseburger
    Henrik Suttmann
    David Schilling
    Lutz Trojan
    Carsten Kempkensteffen
    Stefan Corvin
    Michael J. Mathers
    Patrick J. Bastian
    World Journal of Urology, 2012, 30 : 495 - 503
  • [8] Development of a novel autophagy-inducing multikinase inhibitor for the treatment of castration-resistant prostate cancer
    Qiao, Yuanyuan
    CANCER RESEARCH, 2018, 78 (13)
  • [9] Novel therapeutic approaches for the treatment of castration-resistant prostate cancer
    Heidegger, Isabel
    Massoner, Petra
    Eder, Iris E.
    Pircher, Andreas
    Pichler, Renate
    Aigner, Friedrich
    Bektic, Jasmin
    Horninger, Wolfgang
    Klocker, Helmut
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2013, 138 : 248 - 256
  • [10] Novel strategies in the treatment of castration-resistant prostate cancer (Review)
    Marech, Ilaria
    Vacca, Angelo
    Ranieri, Girolamo
    Gnoni, Antonio
    Dammacco, Franco
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 40 (05) : 1313 - 1320
12345